<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>9110484</identifier>
<setSpec>0034-9887</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Castillo, L</dc:author>
<dc:author>Andresen, M</dc:author>
<dc:author>Dagnino, J</dc:author>
<dc:author>Dougnac, A</dc:author>
<dc:author>Bugedo, G</dc:author>
<dc:author>Espejo, J</dc:author>
<dc:author>Letelier, L M</dc:author>
<dc:author>Hernández, G</dc:author>
<dc:description xml:lang="en">AIM To assess the acute effects of methylene blue infusion, an inhibitor of nitric oxide synthesis, on hemodynamic parameters in patients with refractory septic shock. PATIENTS AND METHODS Fourteen patients admitted to intensive care units with septic shock of diverse etiologies and unable to maintain median arterial pressures over 60 mm Hg with the use of at least 2 vasoactive drugs, were studied. All received a 1 mg/kg bolus of methylene blue Hemodynamic parameters were measured before and 30, 60, 120 and 180 min after the bolus. RESULTS Systolic and diastolic blood pressure and systemic vascular resistance increased in all patients. There were no significant changes in cardiac output, oxygen consumption or extraction. CONCLUSIONS Methylene blue has an acute pressor effect in patients with septic shock.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1996 Apr </dc:date>
<dc:title xml:lang="es">Inhibición de la vía del óxido nítrico en el shock séptico refractario.</dc:title>
<dc:title xml:lang="en">[Inhibition of the nitric oxide pathway in refractory septic shock].</dc:title>
<dc:publisher>Revista medica de Chile</dc:publisher>
</metadata>
</record>
</pubmed-document>
